Your Health, We Care
Release date: 2024-07-10 14:40:59 Recommended: 158
Mobocerinib is a kinase inhibitor suitable for treating locally advanced or metastatic non-small cell lung cancer (NSCLC) in adult patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations. FDA approved tests have detected that the disease progresses during or after platinum chemotherapy. Based on the overall response rate and response duration, the indication was approved under accelerated approval. The continued approval of this indication may depend on the validation and description of clinical benefits in confirmatory trials.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：400Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：397Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：459Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：325Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：533Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：325Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：506Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：399Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：159Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：153Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：171Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：153Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：187Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：167Release date: 2025-12-01
